Skip to content

Wave Life Sciences WVE Income Statement

FY'25FY'24FY'23FY'22
$113.31M+3,005%$3.65M-91.1%
$182.78M+14.5%$159.68M+22.8%$130.01M+12.2%$115.86M-4.9%
$75.33M+27.6%$59.02M+15.1%$51.29M+1.5%$50.51M+9.6%
$258.11M+18.0%$218.71M+20.6%$181.3M+9.0%$166.37M-1.0%
-$215.38M-$68M+58.2%-$162.72M-28.1%
$11.01M-17.8%$13.4M+36.6%$9.81M+521%$1.58M-65.4%
-$204.38M-$58.19M+63.9%-$161.14M-31.6%
$0$0+100%-$677K-199%$681K+434%
-$204.38M-$57.51M+64.5%-$161.82M-32.4%
-$1.21-$0.55+73.9%-$2.11+11.0%
-$211.94M-$63M+59.7%-$156.15M-30.6%
-$215.38M-$68M+58.2%-$162.72M-28.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Wave Life Sciences's revenue?
Wave Life Sciences (WVE) generated $75.8M in revenue over the trailing twelve months, down 32.9% year over year.
Is Wave Life Sciences profitable?
Wave Life Sciences is not currently profitable: it reported a net loss of $183.6M over the trailing twelve months, a -66.5% net margin.
What is Wave Life Sciences's earnings per share?
Wave Life Sciences's diluted EPS over the trailing twelve months is $-1.05.
Where does Wave Life Sciences's income statement data come from?
Every line is extracted from Wave Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.